印度迪氏曼 Dishman Pharmaceuticals & Chemicals公司 www.dishmangroup.com
作為迪氏曼集團進軍中國的第一步。迪氏曼集團于2004年2月在上海外高橋保稅區(qū)注冊成立了全資子公司——迪氏曼國際貿(mào)易（上海）有限公司。經(jīng)過近四年的不泄努力，目前中國已成為迪氏曼集團全球化工原料最主要的采購地。同時面對中國這個巨大的潛在市場，迪氏曼集團決定進一步將生產(chǎn)基地延伸到中國，并于2006年9月在上?；@區(qū)投資成立全資工廠：迪氏曼醫(yī)藥和化工（上海）有限公司。該公司占地75000平方米，依托印度總公司成功獲得GMP證書及美國FDA認(rèn)證的經(jīng)驗，主要生產(chǎn)原料藥，醫(yī)藥中間體，季磷鹽及季銨鹽產(chǎn)品。

Dishman Pharmaceuticals & Chemicals公司（印度Mumbai）也正在打造其全球委托生產(chǎn)生意。公司收購了IO3公司（瑞士Bern，ww.io3s.com），該公司致力于臭氧化學(xué)。IO3S公司現(xiàn)在的資產(chǎn)（不包括對資產(chǎn)的再評估）為200萬美元，收購價低于這個價格。2005年，Dishman公司收購了英國曼徹斯特的委托研發(fā)公司Synprotec公司。Dishman公司還完成了一個面積7500平方英尺的研發(fā)中心，包括一個新CGMP試驗工廠和公司產(chǎn)品Bavla在印度的CGMP生產(chǎn)部門。

Dishman Pharmaceutical & Chemicals Ltd, is a globally-focused company, involved in the manufacture of APIs (active pharmaceutical ingredients), API intermediates, quaternary compounds and fine chemicals. Headquartered in Ahmedabad, India, Dishman has exports spanning all continents.
Dishman is a quality conscious, fast growing, R&D intensive organization with a progressive approach. Our continuous progress has been achieved through the skills of our workforce, commitment to new technologies and dedication to good customer service. 
Since 1998, Dishman has diversified its interests to contract research and manufacture sector. Within a short span of 5 years, Dishman has achieved several contract research and manufacturing projects and is all set to emerge as India’s leading CMO organization (Contract Manufacturing Outsourcing). Dishman is already established as a respected and preferred outsourcing partner to various pharma majors.